Cargando…

GEMO, a National Resource to Study Genetic Modifiers of Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Pathogenic Variant Carriers

Detalles Bibliográficos
Autores principales:	Lesueur, Fabienne, Mebirouk, Noura, Jiao, Yue, Barjhoux, Laure, Belotti, Muriel, Laurent, Maïté, Léone, Mélanie, Houdayer, Claude, Bressac-de Paillerets, Brigitte, Vaur, Dominique, Sobol, Hagay, Noguès, Catherine, Longy, Michel, Mortemousque, Isabelle, Fert-Ferrer, Sandra, Mouret-Fourme, Emmanuelle, Pujol, Pascal, Venat-Bouvet, Laurence, Bignon, Yves-Jean, Leroux, Dominique, Coupier, Isabelle, Berthet, Pascaline, Mari, Véronique, Delnatte, Capucine, Gesta, Paul, Collonge-Rame, Marie-Agnès, Giraud, Sophie, Bonadona, Valérie, Baurand, Amandine, Faivre, Laurence, Buecher, Bruno, Lasset, Christine, Gauthier-Villars, Marion, Damiola, Francesca, Mazoyer, Sylvie, Caputo, Sandrine M., Andrieu, Nadine, Stoppa-Lyonnet, Dominique
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6220051/ https://www.ncbi.nlm.nih.gov/pubmed/30430080 http://dx.doi.org/10.3389/fonc.2018.00490

Ejemplares similares

Variation in breast cancer risk associated with factors related to pregnancies according to truncating mutation location, in the French National BRCA1 and BRCA2 mutations carrier cohort (GENEPSO)
por: Lecarpentier, Julie, et al.
Publicado: (2012)

Diagnostic chest X-rays and breast cancer risk among women with a hereditary predisposition to breast cancer unexplained by a BRCA1 or BRCA2 mutation
por: Ribeiro Guerra, Maximiliano, et al.
Publicado: (2021)

BRCA1/2 carriers: their childbearing plans and theoretical intentions about having preimplantation genetic diagnosis and prenatal diagnosis
por: Julian-Reynier, Claire, et al.
Publicado: (2012)

A new hybrid record linkage process to make epidemiological databases interoperable: application to the GEMO and GENEPSO studies involving BRCA1 and BRCA2 mutation carriers
por: Jiao, Yue, et al.
Publicado: (2021)

Deletion of Chromosomes 13q and 14q Is a Common Feature of Tumors with BRCA2 Mutations
por: Rouault, Audrey, et al.
Publicado: (2012)

Gene‐ and pathway‐level analyses of iCOGS variants highlight novel signaling pathways underlying familial breast cancer susceptibility
por: Lonjou, Christine, et al.
Publicado: (2021)

Targeted Sequencing of the Mitochondrial Genome of Women at High Risk of Breast Cancer without Detectable Mutations in BRCA1/2
por: Blein, Sophie, et al.
Publicado: (2015)

GENESIS: a French national resource to study the missing heritability of breast cancer
por: Sinilnikova, Olga M., et al.
Publicado: (2016)

Clinical outcome of breast cancer in carriers of BRCA1 and BRCA2 mutations according to molecular subtypes
por: Talhouet, Solene De, et al.
Publicado: (2020)

Familial breast cancer and DNA repair genes: Insights into known and novel susceptibility genes from the GENESIS study, and implications for multigene panel testing
por: Girard, Elodie, et al.
Publicado: (2018)

Publisher Correction: Clinical outcome of breast cancer in carriers of BRCA1 and BRCA2 mutations according to molecular subtypes
por: De Talhouet, Solene, et al.
Publicado: (2020)

Anti-müllerian hormone levels and antral follicle count in women with a BRCA1 or BRCA2 germline pathogenic variant: A retrospective cohort study
por: Denis-Laroque, Laurie, et al.
Publicado: (2021)

Effects of BRCA2 cis-regulation in normal breast and cancer risk amongst BRCA2 mutation carriers
por: Maia, Ana-Teresa, et al.
Publicado: (2012)

Adapting palliative radiation therapy for bone metastases during the Covid-19 pandemic: GEMO position paper
por: Thureau, Sébastien, et al.
Publicado: (2020)

BRCA Challenge: BRCA Exchange as a global resource for variants in BRCA1 and BRCA2
por: Cline, Melissa S., et al.
Publicado: (2018)

Performance of multiplicom's BRCA MASTR Dx kit on the detection of BRCA1 and BRCA2 mutations in fresh frozen ovarian and breast tumor samples
por: Badoer, Cindy, et al.
Publicado: (2016)

BRCA1 and BRCA2 protein expressions in an ovotestis of a 46, XX true hermaphrodite
por: Bernard-Gallon, Dominique J, et al.
Publicado: (2001)

Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants
por: Li, Shuai, et al.
Publicado: (2022)

Cancer risk management strategies and perceptions of unaffected women 5 years after predictive genetic testing for BRCA1/2 mutations
por: Julian-Reynier, Claire, et al.
Publicado: (2011)

Oral Contraceptive Use and Breast Cancer Risk: Retrospective and Prospective Analyses From a BRCA1 and BRCA2 Mutation Carrier Cohort Study
por: Schrijver, Lieske H, et al.
Publicado: (2018)

Non-Coding Variants in BRCA1 and BRCA2 Genes: Potential Impact on Breast and Ovarian Cancer Predisposition
por: Santana dos Santos, Elizabeth, et al.
Publicado: (2018)

No Association of Early-Onset Breast or Ovarian Cancer with Early-Onset Cancer in Relatives in BRCA1 or BRCA2 Mutation Families
por: Imbert-Bouteille, Marion, et al.
Publicado: (2021)

Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriers
por: Qian, Frank, et al.
Publicado: (2019)

Associations of height, body mass index, and weight gain with breast cancer risk in carriers of a pathogenic variant in BRCA1 or BRCA2: the BRCA1 and BRCA2 Cohort Consortium
por: Kast, Karin, et al.
Publicado: (2023)

Telomere length, ATM mutation status and cancer risk in Ataxia-Telangiectasia families
por: Renault, Anne-Laure, et al.
Publicado: (2017)

Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers
por: Hakkaart, Christopher, et al.
Publicado: (2022)

The biological effects and clinical implications of BRCA mutations: where do we go from here?
por: Stoppa-Lyonnet, Dominique
Publicado: (2016)

GeMo: a web-based platform for the visualization and curation of genome ancestry mosaics
por: Summo, Marilyne, et al.
Publicado: (2022)

Helping Patients Understand and Cope with BRCA Mutations
por: Makhnoon, Sukh, et al.
Publicado: (2022)

Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants
por: Barnes, Daniel R., et al.
Publicado: (2020)

BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriers
por: Maxwell, Kara N., et al.
Publicado: (2017)

Prediction of the functional impact of missense variants in BRCA1 and BRCA2 with BRCA-ML
por: Hart, Steven N., et al.
Publicado: (2020)

Full in-frame exon 3 skipping of BRCA2 confers high risk of breast and/or ovarian cancer
por: Caputo, Sandrine M., et al.
Publicado: (2018)

BRCA1 and Tip60 determine the cellular response to ultraviolet irradiation through distinct pathways
por: Kranz, Dominique, et al.
Publicado: (2008)

Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2
por: Silvestri, Valentina, et al.
Publicado: (2016)

Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers: an international cohort study
por: Schrijver, Lieske H., et al.
Publicado: (2021)

Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2
por: Mulligan, Anna Marie, et al.
Publicado: (2011)

Epistatic Relationships in the BRCA1-BRCA2 Pathway
por: Scully, Ralph
Publicado: (2011)

A model of the BRCA1/BRCA2 network
por: Pujana, MA, et al.
Publicado: (2005)

Molecular Trajectory of BRCA1 and BRCA2 Mutations
por: Hatano, Yuichiro, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_cjukon05n5l859vs9eeick7p1v